- Home
- HVT vs MREO Comparison
HVT vs MREO Comparison
Compare HVT & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HVT
- MREO
- Stock Information
- Founded
- HVT 1885
- MREO 2015
- Country
- HVT United States
- MREO United Kingdom
- Employees
- HVT N/A
- MREO N/A
- Industry
- HVT Other Specialty Stores
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- HVT Consumer Discretionary
- MREO Health Care
- Exchange
- HVT Nasdaq
- MREO Nasdaq
- Market Cap
- HVT 338.4M
- MREO 311.8M
- IPO Year
- HVT N/A
- MREO N/A
- Fundamental
- Price
- HVT $21.81
- MREO $1.90
- Analyst Decision
- HVT
- MREO Strong Buy
- Analyst Count
- HVT 0
- MREO 5
- Target Price
- HVT N/A
- MREO $7.40
- AVG Volume (30 Days)
- HVT 102.2K
- MREO 1.4M
- Earning Date
- HVT 10-29-2025
- MREO 11-12-2025
- Dividend Yield
- HVT 5.87%
- MREO N/A
- EPS Growth
- HVT N/A
- MREO N/A
- EPS
- HVT 1.17
- MREO N/A
- Revenue
- HVT $741,429,000.00
- MREO $500,000.00
- Revenue This Year
- HVT $3.63
- MREO N/A
- Revenue Next Year
- HVT $8.22
- MREO $72.16
- P/E Ratio
- HVT $18.61
- MREO N/A
- Revenue Growth
- HVT N/A
- MREO N/A
- 52 Week Low
- HVT $17.01
- MREO $1.47
- 52 Week High
- HVT $24.91
- MREO $4.40
- Technical
- Relative Strength Index (RSI)
- HVT 59.29
- MREO 45.27
- Support Level
- HVT $20.06
- MREO $1.98
- Resistance Level
- HVT $23.26
- MREO $2.15
- Average True Range (ATR)
- HVT 0.73
- MREO 0.12
- MACD
- HVT 0.22
- MREO -0.03
- Stochastic Oscillator
- HVT 55.52
- MREO 7.32
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).